1. Home
  2. SRL vs LXEO Comparison

SRL vs LXEO Comparison

Compare SRL & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRL
  • LXEO
  • Stock Information
  • Founded
  • SRL 2017
  • LXEO 2017
  • Country
  • SRL China
  • LXEO United States
  • Employees
  • SRL N/A
  • LXEO N/A
  • Industry
  • SRL Professional Services
  • LXEO
  • Sector
  • SRL Consumer Discretionary
  • LXEO
  • Exchange
  • SRL Nasdaq
  • LXEO Nasdaq
  • Market Cap
  • SRL 120.1M
  • LXEO 140.6M
  • IPO Year
  • SRL N/A
  • LXEO 2023
  • Fundamental
  • Price
  • SRL $8.00
  • LXEO $3.89
  • Analyst Decision
  • SRL
  • LXEO Strong Buy
  • Analyst Count
  • SRL 0
  • LXEO 5
  • Target Price
  • SRL N/A
  • LXEO $23.80
  • AVG Volume (30 Days)
  • SRL 6.3K
  • LXEO 246.3K
  • Earning Date
  • SRL 12-31-2024
  • LXEO 03-04-2025
  • Dividend Yield
  • SRL 3.25%
  • LXEO N/A
  • EPS Growth
  • SRL N/A
  • LXEO N/A
  • EPS
  • SRL N/A
  • LXEO N/A
  • Revenue
  • SRL $33,997,735.00
  • LXEO N/A
  • Revenue This Year
  • SRL N/A
  • LXEO N/A
  • Revenue Next Year
  • SRL N/A
  • LXEO N/A
  • P/E Ratio
  • SRL N/A
  • LXEO N/A
  • Revenue Growth
  • SRL N/A
  • LXEO N/A
  • 52 Week Low
  • SRL $5.74
  • LXEO $3.84
  • 52 Week High
  • SRL $9.99
  • LXEO $19.50
  • Technical
  • Relative Strength Index (RSI)
  • SRL 52.48
  • LXEO 33.05
  • Support Level
  • SRL $7.43
  • LXEO $3.84
  • Resistance Level
  • SRL $8.20
  • LXEO $4.72
  • Average True Range (ATR)
  • SRL 0.28
  • LXEO 0.53
  • MACD
  • SRL 0.02
  • LXEO -0.05
  • Stochastic Oscillator
  • SRL 78.79
  • LXEO 2.27

About SRL Scully Royalty Ltd.

Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

Share on Social Networks: